The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Safety of asparaginase Erwinia chrysanthemi in a compassionate-use trial: Subanalysis of the adolescent/young adult (AYA) and adult patient (Pt) population.
Paul V. Plourde
Employment or Leadership Position - Jazz Pharmaceuticals
Stock Ownership - Jazz Pharmaceuticals
Sima Jeha
No relevant relationships to disclose
Nobuko Hijiya
No relevant relationships to disclose
Frank G. Keller
No relevant relationships to disclose
Susan R. Rheingold
Research Funding - Leukemia Lymphoma Society
Zoann Dreyer
No relevant relationships to disclose
Gary V. H. Dahl
No relevant relationships to disclose
Taheri Mercedes
Employment or Leadership Position - Jazz Pharmaceuticals
Stock Ownership - Jazz Pharmaceuticals
Tim Corn
Employment or Leadership Position - Jazz Pharmaceuticals
Stock Ownership - Jazz Pharmaceuticals